<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"
	"http://www.w3.org/TR/1998/REC-html40-19980424/loose.dtd">
<html>
<head><meta http-equiv="content-type" content="text/html; charset=UTF-8">
<style type="text/css">
 table.main {}
 tr.row {}
 td.cell {}
 div.block {}
 div.paragraph {}
 .font0 { font:5pt Arial, sans-serif; }
 .font1 { font:7pt Arial, sans-serif; }
 .font2 { font:8pt Arial, sans-serif; }
 .font3 { font:9pt Arial, sans-serif; }
 .font4 { font:10pt Arial, sans-serif; }
 .font5 { font:17pt Times New Roman, serif; }

</style>
</head>
<body>
<p><span class="font5">J.P. Morgan</span></p>
<p><span class="font1" style="font-weight:bold;">Asia Pacific Equity Research</span></p>
<p><span class="font3" style="font-weight:bold;">07 September 2016</span></p>
<p><span class="font3" style="font-weight:bold;">Isabella Y. Zhao, CFA</span></p>
<p><span class="font3" style="font-weight:bold;">(852) 2800-8534</span></p>
<p><a href="mailto:isabella.zhao@jpmorgan.com"><span class="font3" style="font-weight:bold;">isabella.zhao@jpmorgan.com</span></a></p>
<p><span class="font2" style="font-weight:bold;">Table 6: Fosun’s Strong Pipeline</span></p>
<p><span class="font3" style="font-weight:bold;">Pipeline: Large molecular biopharmaceuticals</span></p>
<table border="1">
<tr><td style="vertical-align:middle;">
<p><span class="font1" style="font-weight:bold;">Therapeutic area</span></p></td><td style="vertical-align:middle;">
<p><span class="font1" style="font-weight:bold;">Drug name</span></p></td><td style="vertical-align:middle;">
<p><span class="font1" style="font-weight:bold;">Category</span></p></td><td style="vertical-align:middle;">
<p><span class="font1" style="font-weight:bold;">Pre-clinical</span></p></td><td style="vertical-align:top;">
<p><span class="font1" style="font-weight:bold;">Applied for clinical trial</span></p></td><td style="vertical-align:top;">
<p><span class="font1" style="font-weight:bold;">Clinical trial approval</span></p></td><td style="vertical-align:middle;">
<p><span class="font1" style="font-weight:bold;">Clinical trial</span></p></td><td style="vertical-align:top;">
<p><span class="font1" style="font-weight:bold;">Applied for production</span></p></td><td style="vertical-align:top;">
<p><span class="font1" style="font-weight:bold;">Production approved</span></p></td></tr>
<tr><td rowspan="2" style="vertical-align:middle;">
<p><span class="font3" style="font-weight:bold;">Oncology</span></p></td><td rowspan="2" style="vertical-align:top;">
<p><span class="font3" style="font-weight:bold;">CD20 Antibody</span></p></td><td rowspan="2" style="vertical-align:middle;">
<p><span class="font3" style="font-weight:bold;">Bio 2</span></p></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td rowspan="2" style="vertical-align:top;"></td><td rowspan="2" style="vertical-align:top;"></td></tr>
<tr><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td></tr>
<tr><td rowspan="2" style="vertical-align:middle;">
<p><span class="font3" style="font-weight:bold;">Oncology</span></p></td><td rowspan="2" style="vertical-align:top;">
<p><span class="font3" style="font-weight:bold;">Her-2 Anti-Body</span></p></td><td rowspan="2" style="vertical-align:middle;">
<p><span class="font3" style="font-weight:bold;">Bio 2</span></p></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td rowspan="2" style="vertical-align:top;"></td><td rowspan="2" style="vertical-align:top;"></td></tr>
<tr><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td></tr>
<tr><td style="vertical-align:top;"></td><td rowspan="2" style="vertical-align:top;">
<p><span class="font3" style="font-weight:bold;">VEGF Anti-</span></p></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font3" style="font-weight:bold;">Oncology</span></p></td><td style="vertical-align:bottom;">
<p><span class="font3" style="font-weight:bold;">Bio 2</span></p></td><td colspan="4" style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td></tr>
<tr><td style="vertical-align:top;"></td><td style="vertical-align:top;">
<p><span class="font3" style="font-weight:bold;">Body</span></p></td><td style="vertical-align:top;"></td><td colspan="2" style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td></tr>
<tr><td style="vertical-align:middle;">
<p><span class="font3" style="font-weight:bold;">Oncology</span></p></td><td style="vertical-align:top;">
<p><span class="font3" style="font-weight:bold;">EGFR Anti-</span></p>
<p><span class="font3" style="font-weight:bold;">Body</span></p></td><td style="vertical-align:middle;">
<p><span class="font3" style="font-weight:bold;">Bio 2</span></p></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td></tr>
<tr><td style="vertical-align:middle;">
<p><span class="font3" style="font-weight:bold;">Oncology</span></p></td><td style="vertical-align:top;">
<p><span class="font3" style="font-weight:bold;">EGFR Anti-</span></p>
<p><span class="font3" style="font-weight:bold;">Body</span></p></td><td style="vertical-align:middle;">
<p><span class="font3" style="font-weight:bold;">Bio 2</span></p></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td></tr>
<tr><td style="vertical-align:middle;">
<p><span class="font3" style="font-weight:bold;">Oncology</span></p></td><td style="vertical-align:top;">
<p><span class="font3" style="font-weight:bold;">TN Fa Anti-Body</span></p></td><td style="vertical-align:middle;">
<p><span class="font3" style="font-weight:bold;">Bio 2</span></p></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;">
<p><span class="font0">—*</span></p></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td></tr>
</table>
<p><span class="font3" style="font-weight:bold;">Pipeline: Large molecular biopharmaceuticals</span></p>
<table border="1">
<tr><td style="vertical-align:middle;">
<p><span class="font1" style="font-weight:bold;">Therapeutic area</span></p></td><td style="vertical-align:middle;">
<p><span class="font1" style="font-weight:bold;">Drug name</span></p></td><td style="vertical-align:middle;">
<p><span class="font1" style="font-weight:bold;">Category</span></p></td><td style="vertical-align:middle;">
<p><span class="font1" style="font-weight:bold;">Pre-clinical</span></p></td><td style="vertical-align:top;">
<p><span class="font1" style="font-weight:bold;">Applied for clinical trial</span></p></td><td style="vertical-align:top;">
<p><span class="font1" style="font-weight:bold;">Clinical trial approval</span></p></td><td style="vertical-align:middle;">
<p><span class="font1" style="font-weight:bold;">Clinical trial</span></p></td><td style="vertical-align:top;">
<p><span class="font1" style="font-weight:bold;">Applied for production</span></p></td><td style="vertical-align:top;">
<p><span class="font1" style="font-weight:bold;">Production approved</span></p></td></tr>
<tr><td style="vertical-align:top;">
<p><span class="font3" style="font-weight:bold;">Metabolism and alimentary tract</span></p></td><td style="vertical-align:middle;">
<p><span class="font3" style="font-weight:bold;">Liraglutide</span></p></td><td style="vertical-align:middle;">
<p><span class="font3" style="font-weight:bold;">Bio 10</span></p></td><td style="vertical-align:bottom;">
<p><span class="font4">^^^</span></p></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td></tr>
<tr><td rowspan="2" style="vertical-align:top;">
<p><span class="font3" style="font-weight:bold;">Metabolism and alimentary tract</span></p></td><td rowspan="2" style="vertical-align:middle;">
<p><span class="font3" style="font-weight:bold;">Insulin ly spro</span></p></td><td rowspan="2" style="vertical-align:middle;">
<p><span class="font3" style="font-weight:bold;">Bio 15</span></p></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td rowspan="2" style="vertical-align:top;"></td><td rowspan="2" style="vertical-align:top;"></td></tr>
<tr><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td></tr>
<tr><td style="vertical-align:top;">
<p><span class="font3" style="font-weight:bold;">Metabolism and alimentary tract</span></p></td><td style="vertical-align:top;">
<p><span class="font3" style="font-weight:bold;">Insulin glargine</span></p></td><td style="vertical-align:middle;">
<p><span class="font3" style="font-weight:bold;">Bio 15</span></p></td><td style="vertical-align:top;"></td><td style="vertical-align:middle;">
<p><span class="font4">^^^^^^H</span></p></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td></tr>
<tr><td rowspan="2" style="vertical-align:middle;">
<p><span class="font3" style="font-weight:bold;">Metabolism and alimentary tract</span></p></td><td rowspan="2" style="vertical-align:middle;">
<p><span class="font3" style="font-weight:bold;">Biocon human insulin 30R</span></p></td><td rowspan="2" style="vertical-align:middle;">
<p><span class="font3" style="font-weight:bold;">License in</span></p>
<p><span class="font3" style="font-weight:bold;">Bio7</span></p></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td rowspan="2" style="vertical-align:top;"></td><td rowspan="2" style="vertical-align:top;"></td></tr>
<tr><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td></tr>
<tr><td rowspan="2" style="vertical-align:middle;">
<p><span class="font3" style="font-weight:bold;">Metabolism and alimentary tract</span></p></td><td rowspan="2" style="vertical-align:middle;">
<p><span class="font3" style="font-weight:bold;">Biocon human insulin R</span></p></td><td rowspan="2" style="vertical-align:middle;">
<p><span class="font3" style="font-weight:bold;">License in</span></p>
<p><span class="font3" style="font-weight:bold;">Bio7</span></p></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td rowspan="2" style="vertical-align:top;"></td><td rowspan="2" style="vertical-align:top;"></td></tr>
<tr><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td></tr>
<tr><td rowspan="2" style="vertical-align:middle;">
<p><span class="font3" style="font-weight:bold;">Metabolism and alimentary tract</span></p></td><td rowspan="2" style="vertical-align:middle;">
<p><span class="font3" style="font-weight:bold;">Biocon human insulin N</span></p></td><td rowspan="2" style="vertical-align:middle;">
<p><span class="font3" style="font-weight:bold;">License in</span></p>
<p><span class="font3" style="font-weight:bold;">Bio7</span></p></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td rowspan="2" style="vertical-align:top;"></td><td rowspan="2" style="vertical-align:top;"></td></tr>
<tr><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td></tr>
</table>
<p><span class="font3" style="font-weight:bold;">Pipeline: Small molecular Innovative drugs</span></p>
<table border="1">
<tr><td style="vertical-align:middle;">
<p><span class="font1" style="font-weight:bold;">Therapeutic area</span></p></td><td style="vertical-align:middle;">
<p><span class="font1" style="font-weight:bold;">Drug name</span></p></td><td style="vertical-align:middle;">
<p><span class="font1" style="font-weight:bold;">Category</span></p></td><td style="vertical-align:middle;">
<p><span class="font1" style="font-weight:bold;">Pre-clinical</span></p></td><td style="vertical-align:bottom;">
<p><span class="font1" style="font-weight:bold;">Applied for clinical trial</span></p></td><td style="vertical-align:bottom;">
<p><span class="font1" style="font-weight:bold;">Clinical trial approval</span></p></td><td style="vertical-align:middle;">
<p><span class="font1" style="font-weight:bold;">Clinical trial</span></p></td><td style="vertical-align:bottom;">
<p><span class="font1" style="font-weight:bold;">Applied for production</span></p></td><td style="vertical-align:bottom;">
<p><span class="font1" style="font-weight:bold;">Production approved</span></p></td></tr>
<tr><td style="vertical-align:top;">
<p><span class="font3" style="font-weight:bold;">Metabolism and alimentary tract</span></p></td><td style="vertical-align:middle;">
<p><span class="font3" style="font-weight:bold;">FC-109</span></p></td><td style="vertical-align:middle;">
<p><span class="font3" style="font-weight:bold;">Chern 1.1</span></p></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td></tr>
<tr><td rowspan="2" style="vertical-align:top;">
<p><span class="font3" style="font-weight:bold;">Metabolism and alimentary tract</span></p></td><td rowspan="2" style="vertical-align:middle;">
<p><span class="font3" style="font-weight:bold;">FCN-005</span></p></td><td rowspan="2" style="vertical-align:middle;">
<p><span class="font3" style="font-weight:bold;">Chern 1.1</span></p></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td rowspan="2" style="vertical-align:top;"></td><td rowspan="2" style="vertical-align:top;"></td></tr>
<tr><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td></tr>
<tr><td style="vertical-align:top;">
<p><span class="font3" style="font-weight:bold;">Oncology</span></p></td><td style="vertical-align:top;">
<p><span class="font3" style="font-weight:bold;">FC-110</span></p></td><td style="vertical-align:top;">
<p><span class="font3" style="font-weight:bold;">Chem 1.1</span></p></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td></tr>
<tr><td style="vertical-align:top;">
<p><span class="font3" style="font-weight:bold;">Oncology</span></p></td><td style="vertical-align:top;">
<p><span class="font3" style="font-weight:bold;">FC-102</span></p></td><td style="vertical-align:top;">
<p><span class="font3" style="font-weight:bold;">Chern 1.1</span></p></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td></tr>
<tr><td style="vertical-align:top;">
<p><span class="font3" style="font-weight:bold;">Oncology</span></p></td><td style="vertical-align:top;">
<p><span class="font3" style="font-weight:bold;">FC-108</span></p></td><td style="vertical-align:top;">
<p><span class="font3" style="font-weight:bold;">Chem 1.1</span></p></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td></tr>
<tr><td style="vertical-align:top;">
<p><span class="font3" style="font-weight:bold;">Oncology</span></p></td><td style="vertical-align:top;">
<p><span class="font3" style="font-weight:bold;">PA-824</span></p></td><td style="vertical-align:top;">
<p><span class="font3" style="font-weight:bold;">Chem 1.1</span></p></td><td colspan="2" style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td><td style="vertical-align:top;"></td></tr>
</table>
<p><span class="font3" style="font-weight:bold;">11</span></p>
</body>
</html>